Published in J Clin Aesthet Dermatol on January 01, 2017
Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol (2015) 2.05
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol (2011) 1.71
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48
Vitiligo. Lancet (2015) 1.27
A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res (2006) 1.25
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy. JAMA Dermatol (2015) 1.20
Indications and limitations of afamelanotide for treating vitiligo. JAMA Dermatol (2015) 1.09
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol (2014) 1.03
Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). J Am Acad Dermatol (2015) 1.00
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids Health Dis (2004) 0.99
Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study. Br J Dermatol (2012) 0.95
Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways. Int J Mol Med (2008) 0.95
Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option. Indian J Dermatol Venereol Leprol (2012) 0.94
Statins: novel additions to the dermatologic arsenal? Exp Dermatol (2004) 0.90
Treatment of upper- and lower-extremity vitiligo with epidermal grafts after CO2 laser resurfacing with systemic and topical steroids. Aesthetic Plast Surg (2009) 0.90
Melanocytes and keratinocytes transfer using sandpaper technique combined with dermabrasion for stable vitiligo. Dermatol Surg (2011) 0.88
Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. Br J Dermatol (2013) 0.88
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatol (2013) 0.88
Recent onset vitiligo treated with systemic corticosteroid and topical tacrolimus: Need for early treatment in vitiligo. J Dermatol (2010) 0.87
Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States. J Am Acad Dermatol (2011) 0.87
Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol (2013) 0.87
The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed (2011) 0.87
Unstable vitiligo responding to methotrexate. Indian J Dermatol Venereol Leprol (2010) 0.86
Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo. J Dermatol (2010) 0.85
Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Photodermatol Photoimmunol Photomed (2013) 0.84
Repigmentation of leucotrichia in vitiligo with noncultured cellular grafting. Br J Dermatol (2012) 0.84
Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatolog Treat (2010) 0.84
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo. Br J Dermatol (2011) 0.83
Potential advantages of simvastatin as a novel anti-vitiligo arsenal. Eur Rev Med Pharmacol Sci (2013) 0.83
A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. Photodermatol Photoimmunol Photomed (2012) 0.83
A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo. Dermatol Surg (2014) 0.83
Vitiligo surgical, laser, and alternative therapies: a review and case series. J Drugs Dermatol (2013) 0.82
Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. Photodermatol Photoimmunol Photomed (2012) 0.82
Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo. J Dermatolog Treat (2013) 0.82
A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol (2011) 0.81
Oral minocycline in the treatment of vitiligo--a preliminary study. Dermatol Ther (2010) 0.81
Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo. Arch Dermatol Res (2010) 0.81
Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int J Dermatol (2012) 0.81
308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol (2010) 0.81
Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Br J Dermatol (2012) 0.81
Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed (2010) 0.80
Treatment of stable vitiligo by ReCell system. Acta Dermatovenerol Croat (2009) 0.80
Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian J Dermatol Venereol Leprol (2014) 0.80
Surgical interventions for vitiligo: an evidence-based review. Br J Dermatol (2013) 0.80
BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded). Photodermatol Photoimmunol Photomed (2013) 0.80
Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial. Dermatology (2012) 0.79
Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. J Cutan Med Surg (2013) 0.79
Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol (2009) 0.79
Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol (2010) 0.79
Characterization of clinical response in patients with vitiligo undergoing autologous epidermal punch grafting. Dermatol Surg (2011) 0.79
Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study. Photodermatol Photoimmunol Photomed (2013) 0.79
Vitiligo, NB-UVB and tacrolimus: our experience in Naples. G Ital Dermatol Venereol (2014) 0.79
Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. Br J Dermatol (2011) 0.79
Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas. Lasers Surg Med (2015) 0.79
Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study. Dermatol Ther (2015) 0.78
Methotrexate for the treatment of generalized vitiligo. Saudi Pharm J (2013) 0.78
Triple combination of systemic corticosteroids, excimer laser, and topical tacrolimus in the treatment of recently developed localized vitiligo. Ann Dermatol (2015) 0.78
Suction blister grafting for vitiligo: efficacy and clinical predictive factors. Dermatol Surg (2015) 0.78
The effect of latanoprost on vitiligo: a preliminary comparative study. Int J Dermatol (2014) 0.77
Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study. Photomed Laser Surg (2011) 0.77
Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study. J Eur Acad Dermatol Venereol (2012) 0.77
Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction? Dermatol Surg (2011) 0.77
Efficacy and safety of autologous cultured melanocytes delivered on poly (DL-lactic acid) film: a prospective, open-label, randomized, multicenter study. Dermatol Surg (2012) 0.77
Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo. An Bras Dermatol (2012) 0.77
Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J Eur Acad Dermatol Venereol (2011) 0.77
Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms. J Am Acad Dermatol (2012) 0.77
Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population. J Eur Acad Dermatol Venereol (2011) 0.76
Segmental vitiligo treated by the combination of epidermal grafting and systemic corticosteroids. Dermatol Surg (2010) 0.76
Melanocytes transplantation in patients with vitiligo using needling micrografting technique. J Drugs Dermatol (2013) 0.76
Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial. Dermatol Res Pract (2014) 0.76
Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial. Clin Exp Dermatol (2013) 0.76
A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo. Dermatology (2015) 0.76